Old Web
English
Sign In
Acemap
>
Paper
>
Combined Ibrutinib and Venetoclax in Patients with Treatment-Naïve High-Risk Chronic Lymphocytic Leukemia (CLL)
Combined Ibrutinib and Venetoclax in Patients with Treatment-Naïve High-Risk Chronic Lymphocytic Leukemia (CLL)
2018
Nitin Jain
Michael J. Keating
Philip A Thompson
Alessandra Ferrajoli
Jan Andreas Burger
Gautam Borthakur
Koichi Takahashi
Zeev Estrov
Nathan Fowler
Tapan Kadia
Marina Konopleva
Yesid Alvarado
Musa Yilmaz
Courtney D. DiNardo
Prithviraj Bose
Maro Ohanian
Naveen Pemmaraju
Elias Jabbour
Koji Sasaki
Rashmi Kanagal Shamanna
Keyur P. Patel
Jeffrey L. Jorgensen
Naveen Garg
Xuemei Wang
Katrina Sondermann
Nichole Cruz
Chongjuan Wei
Ana Ayala
William K Plunkett
Hagop M. Kantarjian
Varsha V Gandhi
William G. Wierda
Keywords:
Chronic lymphocytic leukemia
Immunology
Medicine
Venetoclax
Ibrutinib
in patient
therapy naive
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
18
Citations
NaN
KQI
[]